539 related articles for article (PubMed ID: 22273844)
1. Ultrasmall water-soluble metal-iron oxide nanoparticles as T1-weighted contrast agents for magnetic resonance imaging.
Zeng L; Ren W; Zheng J; Cui P; Wu A
Phys Chem Chem Phys; 2012 Feb; 14(8):2631-6. PubMed ID: 22273844
[TBL] [Abstract][Full Text] [Related]
2. Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.
Hu F; Jia Q; Li Y; Gao M
Nanotechnology; 2011 Jun; 22(24):245604. PubMed ID: 21508500
[TBL] [Abstract][Full Text] [Related]
3. Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging.
Taboada E; Rodríguez E; Roig A; Oró J; Roch A; Muller RN
Langmuir; 2007 Apr; 23(8):4583-8. PubMed ID: 17355158
[TBL] [Abstract][Full Text] [Related]
4. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.
Kim BH; Lee N; Kim H; An K; Park YI; Choi Y; Shin K; Lee Y; Kwon SG; Na HB; Park JG; Ahn TY; Kim YW; Moon WK; Choi SH; Hyeon T
J Am Chem Soc; 2011 Aug; 133(32):12624-31. PubMed ID: 21744804
[TBL] [Abstract][Full Text] [Related]
5. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate.
Ma HL; Qi XR; Maitani Y; Nagai T
Int J Pharm; 2007 Mar; 333(1-2):177-86. PubMed ID: 17074454
[TBL] [Abstract][Full Text] [Related]
7. Ultrasmall manganese ferrite nanoparticles as positive contrast agent for magnetic resonance imaging.
Li Z; Wang SX; Sun Q; Zhao HL; Lei H; Lan MB; Cheng ZX; Wang XL; Dou SX; Max Lu GQ
Adv Healthc Mater; 2013 Jul; 2(7):958-64. PubMed ID: 23322490
[No Abstract] [Full Text] [Related]
8. Relaxation behavior study of ultrasmall superparamagnetic iron oxide nanoparticles at ultralow and ultrahigh magnetic fields.
Wang W; Dong H; Pacheco V; Willbold D; Zhang Y; Offenhaeusser A; Hartmann R; Weirich TE; Ma P; Krause HJ; Gu Z
J Phys Chem B; 2011 Dec; 115(49):14789-93. PubMed ID: 21972868
[TBL] [Abstract][Full Text] [Related]
9. Ultrasmall iron oxide nanoparticles for biomedical applications: improving the colloidal and magnetic properties.
Costo R; Bello V; Robic C; Port M; Marco JF; Puerto Morales M; Veintemillas-Verdaguer S
Langmuir; 2012 Jan; 28(1):178-85. PubMed ID: 22103685
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of the 1H NMR relaxation enhancement produced by iron oxide and core-shell iron-iron oxide nanoparticles.
Miguel OB; Gossuin Y; Morales MP; Gillis P; Muller RN; Veintemillas-Verdaguer S
Magn Reson Imaging; 2007 Dec; 25(10):1437-41. PubMed ID: 17566686
[TBL] [Abstract][Full Text] [Related]
11. One-pot synthesis of pegylated ultrasmall iron-oxide nanoparticles and their in vivo evaluation as magnetic resonance imaging contrast agents.
Lutz JF; Stiller S; Hoth A; Kaufner L; Pison U; Cartier R
Biomacromolecules; 2006 Nov; 7(11):3132-8. PubMed ID: 17096542
[TBL] [Abstract][Full Text] [Related]
12. Water-soluble superparamagnetic magnetite nanoparticles with biocompatible coating for enhanced magnetic resonance imaging.
Xiao L; Li J; Brougham DF; Fox EK; Feliu N; Bushmelev A; Schmidt A; Mertens N; Kiessling F; Valldor M; Fadeel B; Mathur S
ACS Nano; 2011 Aug; 5(8):6315-24. PubMed ID: 21790153
[TBL] [Abstract][Full Text] [Related]
13. Magnetic iron oxide nanoparticles for biomedical applications.
Laurent S; Bridot JL; Elst LV; Muller RN
Future Med Chem; 2010 Mar; 2(3):427-49. PubMed ID: 21426176
[TBL] [Abstract][Full Text] [Related]
14. Labeling transplanted mice islet with polyvinylpyrrolidone coated superparamagnetic iron oxide nanoparticles for in vivo detection by magnetic resonance imaging.
Huang H; Xie Q; Kang M; Zhang B; Zhang H; Chen J; Zhai C; Yang D; Jiang B; Wu Y
Nanotechnology; 2009 Sep; 20(36):365101. PubMed ID: 19687538
[TBL] [Abstract][Full Text] [Related]
15. Long-term investigation on the phase stability, magnetic behavior, toxicity, and MRI characteristics of superparamagnetic Fe/Fe-oxide core/shell nanoparticles.
Masoudi A; Hosseini HR; Reyhani SM; Shokrgozar MA; Oghabian MA; Ahmadi R
Int J Pharm; 2012 Dec; 439(1-2):28-40. PubMed ID: 23058926
[TBL] [Abstract][Full Text] [Related]
16. Aqueous dispersions of magnetite nanoparticles with NH3+ surfaces for magnetic manipulations of biomolecules and MRI contrast agents.
Shieh DB; Cheng FY; Su CH; Yeh CS; Wu MT; Wu YN; Tsai CY; Wu CL; Chen DH; Chou CH
Biomaterials; 2005 Dec; 26(34):7183-91. PubMed ID: 15964622
[TBL] [Abstract][Full Text] [Related]
17. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents.
Lee N; Hyeon T
Chem Soc Rev; 2012 Apr; 41(7):2575-89. PubMed ID: 22138852
[TBL] [Abstract][Full Text] [Related]
18. Characterization of aqueous dispersions of Fe(3)O(4) nanoparticles and their biomedical applications.
Cheng FY; Su CH; Yang YS; Yeh CS; Tsai CY; Wu CL; Wu MT; Shieh DB
Biomaterials; 2005 Mar; 26(7):729-38. PubMed ID: 15350777
[TBL] [Abstract][Full Text] [Related]
19. Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI.
Faucher L; Tremblay M; Lagueux J; Gossuin Y; Fortin MA
ACS Appl Mater Interfaces; 2012 Sep; 4(9):4506-15. PubMed ID: 22834680
[TBL] [Abstract][Full Text] [Related]
20. Novel magnetic iron oxide nanoparticles coated with poly(ethylene imine)-g-poly(ethylene glycol) for potential biomedical application: synthesis, stability, cytotoxicity and MR imaging.
Schweiger C; Pietzonka C; Heverhagen J; Kissel T
Int J Pharm; 2011 Apr; 408(1-2):130-7. PubMed ID: 21315813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
